NCT03633305

Brief Summary

The primary objective of this pragmatic clinical trial is to evaluate the efficacy, feasibility, and adaptability of pharmacological and non-pharmacological treatments for insomnia disorder, delivered in primary care clinics. The second objective is to evaluate the efficacy of a sequential (stepped care) approach for persistent insomnia.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
300

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Sep 2018

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 17, 2018

Completed
1 month until next milestone

First Posted

Study publicly available on registry

August 16, 2018

Completed
16 days until next milestone

Study Start

First participant enrolled

September 1, 2018

Completed
5.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2023

Completed
Last Updated

April 6, 2022

Status Verified

April 1, 2022

Enrollment Period

5.3 years

First QC Date

July 17, 2018

Last Update Submit

April 5, 2022

Conditions

Keywords

InsomniaPragmatic Clinical TrialDrug TherapyCognitive Behavior TherapyPrimary Care

Outcome Measures

Primary Outcomes (2)

  • Remission of insomnia

    Insomnia Severity Index score (average of two consecutive weeks \< 8, with none \> 10)

    Post-1 (after 6-week treatment phase 1)

  • Remission of insomnia

    Insomnia Severity Index score (average of two consecutive weeks \< 8, with none \> 10)

    Post-2 (after 6-week treatment phase 2)

Secondary Outcomes (22)

  • Total sleep time from sleep diary

    Post-1 (after 6-week treatment phase 1)

  • Total sleep time from sleep diary

    Post-2 (after 6-week treatment phase 2)

  • Total wake time from sleep diary

    Post-1 (after 6-week treatment phase 1)

  • Total wake time from sleep diary

    Post-2 (after 6-week treatment phase 2)

  • Sleep efficiency from sleep diary

    Post-1 (after 6-week treatment phase 1)

  • +17 more secondary outcomes

Study Arms (6)

Treatment as usual

ACTIVE COMPARATOR

Hypnotics - Medication used 1 to 7 nights/week for 6 to 8 weeks

Drug: Hypnotics

Online cognitive behavior therapy

EXPERIMENTAL

Online CBT- Internet self-help program for insomnia with 6 cores

Behavioral: Online CBT

Treatment as usual + Online CBT

EXPERIMENTAL

Hypnotics - Medication used 1 to 7 nights/week for 6 to 8 weeks Online CBT- Internet self-help program for insomnia with 6 cores

Drug: HypnoticsBehavioral: Online CBT

Medication

EXPERIMENTAL

Hypnotics - Medication used 1 to 7 nights/week for 6 to 8 weeks (arms 1, 3, 4)

Drug: Hypnotics

In-person cognitive behavior therapy

EXPERIMENTAL

Face-to-face CBT- Face-to-face therapy with 3 to 4 individual sessions in a period of 6 to 8 weeks.

Behavioral: Face-to-face CBT

No additional treatment

NO INTERVENTION

Interventions

Medication used 1 to 7 nights/week for 6 to 8 weeks.

MedicationTreatment as usualTreatment as usual + Online CBT
Online CBTBEHAVIORAL

Internet self-help program for insomnia with 6 cores.

Online cognitive behavior therapyTreatment as usual + Online CBT

Face-to-face therapy with 3 to 4 individual sessions in a period of 6 to 8 weeks.

In-person cognitive behavior therapy

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Aged 18 years or over
  • Meeting criteria for insomnia disorder
  • Registered patient at one of the primary care clinics participating in the study
  • Fluent in French
  • Computer and internet access

You may not qualify if:

  • Unstable or untreated psychiatric disorder
  • Lifetime psychotic or bipolar disorder
  • Current suicide risk
  • Progressive or unstable medical disorder
  • Untreated sleep disorder other than insomnia
  • Use of medication altering sleep
  • Irregular or atypical sleep-wake schedule
  • Current or planned pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Laval University

Québec, Quebec, G1K 0A6, Canada

RECRUITING

Related Publications (2)

  • Cheung JMY, Ritterband LM, Chen SJ, Ivers H, Morin CM. Stepped-Care Management of Insomnia: Treatment Choices Guided by a Patient Decision Aid in a Pragmatic Nonrandomized Clinical Trial Setting. J Sleep Res. 2025 Jun 26:e70127. doi: 10.1111/jsr.70127. Online ahead of print.

  • Morin CM, Chen SJ, Lemieux K, Ivers H, Cheung JMY, Lamy M, Ritterband L. Stepped care for insomnia in primary care using digital and face-to-face cognitive behavioral therapies: A pragmatic nonrandomized clinical trial. Sleep Med. 2025 Aug;132:106551. doi: 10.1016/j.sleep.2025.106551. Epub 2025 May 3.

MeSH Terms

Conditions

Sleep Initiation and Maintenance Disorders

Interventions

Hypnotics and Sedatives

Condition Hierarchy (Ancestors)

Sleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System DiseasesMental Disorders

Intervention Hierarchy (Ancestors)

Central Nervous System DepressantsPhysiological Effects of DrugsPharmacologic ActionsChemical Actions and UsesCentral Nervous System AgentsTherapeutic Uses

Study Officials

  • Charles Morin, PhD

    Université Laval Centre d'étude des troubles du sommeil

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
SEQUENTIAL
Model Details: The study involves two treatment phases of six to eight weeks. In the first phase, participants choose medication (treatment as usual), online cognitive behavior therapy, or online cognitive behavior therapy combined with medication. Participants enter a second treatment phase if they still experience insomnia after the first treatment. The treatment arms for the second phase are medication, in-person cognitive-behavior therapy, or no additional treatment.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

July 17, 2018

First Posted

August 16, 2018

Study Start

September 1, 2018

Primary Completion

December 1, 2023

Study Completion

December 1, 2023

Last Updated

April 6, 2022

Record last verified: 2022-04

Data Sharing

IPD Sharing
Will not share

Locations